Cefepime/Avibatam

头孢吡肟/阿维巴坦

Report date: 2025/04/20 20:00:03

Base Information

Drug NameCefepime/Avibatam
Drug Alias NameYK-1169
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsHospital-acquired pneumoniaLower Respiratory Tract InfectionsUrinary Tract Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Cefepime Hydrochloride
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Libowei Pharmaceutical Co LtdNanjing Yoko Biomedical Co LtdNanjing Yoko Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaLower Respiratory Tract InfectionsUrinary Tract Infections +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A